Affiliation:
1. National Hospital of Traditional Medicine , Hanoi , Vietnam
2. Research and Innovation Platform , Max Biocare Institute , Melbourne , Australia
3. Max Biocare Institute , Research and Innovation Platform , Level 1-2, 667 Chapel St, South Yarra , Melbourne, Victoria, 3141 , Australia
Abstract
Abstract
Background
To evaluate the safety, efficacy and tolerability of a combination micronutrient and polyherbal preparation (GoutFighter
TM) for gout management.
Methods
A single arm, open-label pilot study was conducted at the National Hospital for Traditional Medicine in Vietnam. Participants (n=35 recruited) diagnosed with chronic gout received four tablets of GoutFighter
TM daily over a 45-day period. Efficacy was assessed by changes in pain, swelling and blood uric acid levels, with concurrent safety and tolerability assessments.
Results
A total of 27 (85.2% male) participants (mean ± SD age, 54.2 ± 12.5 years; BMI, 24.2 ± 3.6 kg/m2) with gout (median [IQR], years since diagnosis 4.0 [3.0–8.0]) completed intervention. In relation to safety, there were no significant changes in vital signs, blood biochemistry or cell counts. In regard to efficacy, the degree of perceived pain and frequency of joint swelling significantly declined after 15 and 30 days of treatment, respectively, and remained so until the end of trial. Mean blood uric acid levels also declined by 25.8 μmol/L (95% CI, 3.7 to 48.0, p=0.024). Overall, the predominance of participants (96.3%) responded favorably to treatment (p<0.0001) and GoutFighter
TM was well tolerated, with no serious adverse events.
Conclusion
Clinically relevant doses of GoutFighter
TM were found to be generally safe, well-tolerated and effective for the short-term, symptomatic relief of chronic gout. GoutFighter
TM appears to be suitable as an adjunctive treatment in lifestyle programs for gout management, and further investigation in placebo-controlled trials is therefore warranted.
Subject
Complementary and alternative medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献